연구동향 분석

Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C

전백규 박의주 이웅철 장재영 정승원 김영돈 천갑진 조영신 이세환 김홍수 이윤나 김상균 김영석 김부성 2019년

논문상세정보
인용/피인용
' Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Blood platelets
  • Predictor
  • Sustained virological response
  • chronic
  • hepatitis c
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
263 0

0.0%

' Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C' 의 참고문헌

  • 우리나라 만성 C형간염 환자에서 페그인터페론과 리바비린의 병합치료에 대한 효과
    강명주 [2008]
  • Trends in the prevalence of thrombocytopenia among individuals infected with hepatitis C virus in the United States, 1999-2008
    Kauf TL [2012]
  • Thrombocytopenia in chronic hepatitis C
    Olariu M [2010]
  • The global burden of hepatitis C
    Lavanchy D [2009]
  • The cost-effectiveness of novel direct acting antiviral agent therapies for the treatment of chronic hepatitis C
  • Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients
    Yu ML [2011]
  • Relationship between adherence to hepatitis C virus therapy and virologic outcomes : a cohort study
    Lo Re V 3rd [2011]
  • Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors
    Shirakawa H [2008]
  • Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
    Kurosaki M [2011]
  • Predictors of response to therapy for chronic hepatitis C
    Ferenci P [2004]
  • Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin
    Yu JW [2007]
  • Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load
    Kim SR [2012]
  • Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis
    이홍섭 [2010]
  • Predicting antiviral treatment response in chronic hepatitis C: how accurate and how soon?
    Lee SS [2003]
  • Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin
    Lyoo K [2011]
  • Platelet count and sustained virological response in hepatitis C treatment
    Kanda T [2013]
  • Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C : a randomized study of treatment duration and ribavirin dose
  • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
    Fried MW [2002]
  • Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population
    Jin YJ [2013]
  • Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus
    Thompson AJ [2010]
  • High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice
    Nae Yun Heo [2013]
  • Hepatitis C genotype 4 : what we know and what we don't yet know
    Kamal SM [2008]
  • Hepatitis C and hepatocellular carcinoma
  • Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
    Davis GL [2003]
  • EASL Clinical Practice Guidelines : management of hepatitis C virus infection
  • Diagnosis, management, and treatment of hepatitis C : an update
    Ghany MG [2009]
  • Current status of hepatitis C virus infection in Korea
    Suh DJ [2006]
  • Current status of and strategies for hepatitis C control in South Korea
    Kim BK [2017]
  • Clinical relevance of viral dynamics and genotypes in hepatitis B virus
  • Clinical practice. Chronic hepatitis C infection
    Rosen HR. [2011]
  • Causes of thrombocytopenia in chronic hepatitis C viral infection
    Osada M [2012]
  • Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
  • A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients
    Idrees M [2009]